London, 24 February 2015: TechNavio, the independent tech-focused global research firm, has published a report on the Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019, which is expected to grow at a CAGR of 8.16 percent from 2014-2019.
In 2009, it was estimated that sleep apnea affected over 100 million people worldwide and many people were still undiagnosed. The prevalence of sleep apnea has increased over the years. Several organizations like American Sleep Apnea Association and National Sleep Foundation are helping snorers and their partners improve their sleep.
“Home sleep diagnostic devices are accurate for people with moderate to severe apnea, as they are considered less obtrusive and are employed in the familiar home setting of the patients,” says Faisal Ghaus, Vice President of TechNavio.
“Home testing devices are more cost-effective than an in-lab sleep study and therefore it is expected to have a positive effect on the market growth in the coming years.”
Key Market Drivers
- High Prevalence of Sleep Apnea
- Rise in Consumer Awareness
- Increase in Aging Population
- Advances in Technology
Key Market Trends
- High Adoption of Home Diagnostics
- Growing Preference for Oral Appliances
- Increase in M&A
Key Market Vendors
- Fisher & Paykel Healthcare Ltd.
- Philips Healthcare
- ResMed Inc.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
